Name	Gene(s)	Protein change	Condition(s)	Accession	GRCh37Chromosome	GRCh37Location	GRCh38Chromosome	GRCh38Location	VariationID	AlleleID(s)	dbSNP ID	Canonical SPDI	Variant type	Molecular consequence	Germline classification	Germline date last evaluated	Germline review status	Somatic clinical impact	Somatic clinical impact date last evaluated	Somatic clinical impact review status	Oncogenicity classification	Oncogenicity date last evaluated	Oncogenicity review status	
NM_000767.5(CYP2B6):c.20T>C (p.Leu7Pro)	CYP2B6	L7P	not specified	VCV003837837	19	41497230	19	40991325	3837837	3952458		NC_000019.10:40991324:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 27, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.41G>A (p.Gly14Glu)	CYP2B6	G14E	not specified	VCV003837838	19	41497251	19	40991346	3837838	3952459		NC_000019.10:40991345:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 12, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.46T>C (p.Leu16=)	CYP2B6		CYP2B6-related disorder	VCV003043157	19	41497256	19	40991351	3043157	3203441	rs34477445	NC_000019.10:40991350:T:C	single nucleotide variant	synonymous variant	Likely benign	Jun 28, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.54C>A (p.Leu18=)	CYP2B6		CYP2B6-related disorder	VCV003048896	19	41497264	19	40991359	3048896	3216354	rs150742423	NC_000019.10:40991358:C:A	single nucleotide variant	synonymous variant	Likely benign	Nov 25, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.62A>T (p.Gln21Leu)	CYP2B6	Q21L	CYP2B6-related disorder	VCV003041988	19	41497272	19	40991367	3041988	3210483	rs34883432	NC_000019.10:40991366:A:T	single nucleotide variant	missense variant	Likely benign	May 9, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.80A>T (p.His27Leu)	CYP2B6	H27L	not specified	VCV003499173	19	41497290	19	40991385	3499173	3658233		NC_000019.10:40991384:A:T	single nucleotide variant	missense variant	Uncertain significance	Nov 11, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.81T>A (p.His27Gln)	CYP2B6	H27Q	not specified	VCV004008823	19	41497291	19	40991386	4008823	4125964		NC_000019.10:40991385:T:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.82_83insGC (p.Asp28fs)	CYP2B6	D28fs	not specified	VCV001301545	19	41497292 - 41497293	19	40991387 - 40991388	1301545	1291830	rs781463375	NC_000019.10:40991387::GC	Insertion	frameshift variant	Benign	Jan 2, 2020	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.86_87del (p.Arg29fs)	CYP2B6	R29fs	not specified	VCV001301546	19	41497295 - 41497296	19	40991390 - 40991391	1301546	1291831	rs750679089	NC_000019.10:40991389:CGC:C	Deletion	frameshift variant	Benign	Jan 2, 2020	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.88C>T (p.Leu30Phe)	CYP2B6	L30F	not specified	VCV003499174	19	41497298	19	40991393	3499174	3658234		NC_000019.10:40991392:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 21, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.119T>C (p.Leu40Ser)	CYP2B6	L40S	not specified	VCV004008821	19	41497329	19	40991424	4008821	4125962		NC_000019.10:40991423:T:C	single nucleotide variant	missense variant	Uncertain significance	May 26, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.130C>G (p.Leu44Val)	CYP2B6	L44V	not specified	VCV002308388	19	41497340	19	40991435	2308388	2300760	rs771501582	NC_000019.10:40991434:C:G	single nucleotide variant	missense variant	Uncertain significance	Aug 17, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.139G>A (p.Asp47Asn)	CYP2B6	D47N	not specified	VCV003499170	19	41497349	19	40991444	3499170	3658230		NC_000019.10:40991443:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.182A>T (p.Lys61Ile)	CYP2B6	K61I	not specified	VCV004008822	19	41509916	19	41004011	4008822	4125963		NC_000019.10:41004010:A:T	single nucleotide variant	missense variant	Uncertain significance	May 18, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.186T>A (p.Tyr62Ter)	CYP2B6	Y62*	Efavirenz response	VCV000143910	19	41509920	19	41004015	143910	153633	rs281864907	NC_000019.10:41004014:T:A	single nucleotide variant	nonsense	drug response	Oct 11, 2012	no assertion criteria provided							
NM_000767.5(CYP2B6):c.193G>A (p.Val65Ile)	CYP2B6	V65I	CYP2B6-related disorder	VCV003779214	19	41509927	19	41004022	3779214	3895200		NC_000019.10:41004021:G:A	single nucleotide variant	missense variant	Uncertain significance	May 20, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.202G>A (p.Val68Ile)	CYP2B6	V68I	not specified	VCV003079499	19	41509936	19	41004031	3079499	3239649	rs199704872	NC_000019.10:41004030:G:A	single nucleotide variant	missense variant	Uncertain significance	Feb 28, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.293G>A (p.Arg98Gln)	CYP2B6	R98Q	not specified	VCV002319998	19	41510027	19	41004122	2319998	2314084	rs372295360	NC_000019.10:41004121:G:A	single nucleotide variant	missense variant	Uncertain significance	Oct 26, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.304G>T (p.Ala102Ser)	CYP2B6	A102S	not specified	VCV002589387	19	41510038	19	41004133	2589387	2764403	rs148009906	NC_000019.10:41004132:G:T	single nucleotide variant	missense variant	Uncertain significance	Aug 10, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.313G>C (p.Asp105His)	CYP2B6	D105H	not specified	VCV002623340	19	41510047	19	41004142	2623340	2790156	rs1435601876	NC_000019.10:41004141:G:C	single nucleotide variant	missense variant	Uncertain significance	Sep 13, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.329G>T (p.Gly110Val)	CYP2B6	G110V	Efavirenz response	VCV000120172	19	41510063	19	41004158	120172	125780	rs186335453	NC_000019.10:41004157:G:T	single nucleotide variant	missense variant	drug response	May 15, 2015	no assertion criteria provided							
NM_000767.5(CYP2B6):c.332A>G (p.Tyr111Cys)	CYP2B6	Y111C	not specified	VCV002527009	19	41510066	19	41004161	2527009	2698192	rs780098230	NC_000019.10:41004160:A:G	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.341T>C (p.Ile114Thr)	CYP2B6	I114T	Efavirenz response	VCV000120173	19	41510208	19	41004303	120173	125781	rs139801276	NC_000019.10:41004302:T:C	single nucleotide variant	missense variant	drug response	May 15, 2015	no assertion criteria provided							
NM_000767.5(CYP2B6):c.394A>G (p.Met132Val)	CYP2B6	M132V	not specified	VCV004008825	19	41510261	19	41004356	4008825	4125966		NC_000019.10:41004355:A:G	single nucleotide variant	missense variant	Uncertain significance	Apr 21, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.415A>G (p.Lys139Glu)	CYP2B6	K139E	not provided	VCV003033395	19	41510282	19	41004377	3033395	3201912	rs12721655	NC_000019.10:41004376:A:G	single nucleotide variant	missense variant	Likely benign	Oct 1, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.419G>A (p.Arg140Gln)	CYP2B6	R140Q	not provided	VCV002649918	19	41510286	19	41004381	2649918	2808715	rs35773040	NC_000019.10:41004380:G:A	single nucleotide variant	missense variant	Likely benign	Jan 1, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.422G>A (p.Ser141Asn)	CYP2B6	S141N	not specified	VCV004008827	19	41510289	19	41004384	4008827	4125968		NC_000019.10:41004383:G:A	single nucleotide variant	missense variant	Uncertain significance	May 19, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.445G>A (p.Glu149Lys)	CYP2B6	E149K	not specified	VCV002375701	19	41510312	19	41004407	2375701	2370015	rs770483455	NC_000019.10:41004406:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 7, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.461T>C (p.Ile154Thr)	CYP2B6	I154T	not specified	VCV003079500	19	41510328	19	41004423	3079500	3239650	rs775473137	NC_000019.10:41004422:T:C	single nucleotide variant	missense variant	Uncertain significance	Mar 11, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.472C>T (p.Arg158Trp)	CYP2B6	R158W	not specified	VCV002478235	19	41510339	19	41004434	2478235	2461325	rs183040778	NC_000019.10:41004433:C:T	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.483G>T (p.Lys161Asn)	CYP2B6	K161N	not specified	VCV002259870	19	41510350	19	41004445	2259870	2251439	rs1381773828	NC_000019.10:41004444:G:T	single nucleotide variant	missense variant	Uncertain significance	Nov 9, 2021	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.490C>T (p.Leu164Phe)	CYP2B6	L164F	not specified	VCV003079501	19	41512815	19	41006910	3079501	3239651	rs373819171	NC_000019.10:41006909:C:T	single nucleotide variant	missense variant	Uncertain significance	Oct 13, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.516G>T (p.Gln172His)	CYP2B6	Q172H	efavirenz response - Metabolism/PK|efavirenz response - Toxicity|nevirapine response - Metabolism/PK	VCV000029671	19	41512841	19	41006936	29671	38626	rs3745274	NC_000019.10:41006935:G:T	single nucleotide variant	missense variant	drug response	Mar 24, 2021	reviewed by expert panel							
NM_000767.5(CYP2B6):c.523A>G (p.Thr175Ala)	CYP2B6	T175A	not specified	VCV002591909	19	41512848	19	41006943	2591909	2758135	rs140582290	NC_000019.10:41006942:A:G	single nucleotide variant	missense variant	Uncertain significance	Aug 1, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.548T>G (p.Val183Gly)	CYP2B6	V183G	Efavirenz response	VCV000120174	19	41512873	19	41006968	120174	125782	rs373489637	NC_000019.10:41006967:T:G	single nucleotide variant	missense variant	drug response	May 15, 2015	no assertion criteria provided							
NM_000767.5(CYP2B6):c.571C>G (p.Gln191Glu)	CYP2B6	Q191E	not specified	VCV003837833	19	41512896	19	41006991	3837833	3952454		NC_000019.10:41006990:C:G	single nucleotide variant	missense variant	Uncertain significance	Jan 23, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.576T>A (p.Asp192Glu)	CYP2B6	D192E	not specified	VCV003837836	19	41512901	19	41006996	3837836	3952457		NC_000019.10:41006995:T:A	single nucleotide variant	missense variant	Uncertain significance	Mar 7, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.593T>C (p.Met198Thr)	CYP2B6	M198T	Efavirenz response	VCV000143912	19	41512918	19	41007013	143912	153635	rs36079186	NC_000019.10:41007012:T:C	single nucleotide variant	missense variant	drug response	Jan 1, 2006	no assertion criteria provided							
NM_000767.5(CYP2B6):c.619T>C (p.Ser207Pro)	CYP2B6	S207P	not specified	VCV003079502	19	41512944	19	41007039	3079502	3239652	rs558163100	NC_000019.10:41007038:T:C	single nucleotide variant	missense variant	Uncertain significance	Jan 9, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.635T>C (p.Val212Ala)	CYP2B6	V212A	not specified	VCV003499172	19	41512960	19	41007055	3499172	3658232		NC_000019.10:41007054:T:C	single nucleotide variant	missense variant	Uncertain significance	Oct 28, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.637T>C (p.Phe213Leu)	CYP2B6	F213L	Efavirenz response	VCV000120175	19	41512962	19	41007057	120175	125783	rs371424910	NC_000019.10:41007056:T:C	single nucleotide variant	missense variant	drug response	May 1, 2013	no assertion criteria provided							
NM_000767.5(CYP2B6):c.714G>A (p.Leu238=)	CYP2B6		CYP2B6-related disorder	VCV003038056	19	41515192	19	41009287	3038056	3206999	rs376359134	NC_000019.10:41009286:G:A	single nucleotide variant	synonymous variant	Likely benign	Nov 18, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.723C>A (p.Ile241=)	CYP2B6		CYP2B6-related disorder	VCV003045634	19	41515201	19	41009296	3045634	3211527	rs35349987	NC_000019.10:41009295:C:A	single nucleotide variant	synonymous variant	Likely benign	Feb 28, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.733A>G (p.Ile245Val)	CYP2B6	I245V	not specified	VCV003837831	19	41515211	19	41009306	3837831	3952452		NC_000019.10:41009305:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 14, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.748G>A (p.Glu250Lys)	CYP2B6	E250K	not specified	VCV004008828	19	41515226	19	41009321	4008828	4125969		NC_000019.10:41009320:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 7, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.777C>T (p.Ser259=)	CYP2B6		CYP2B6-related disorder	VCV003040512	19	41515255	19	41009350	3040512	3214041	rs45482602	NC_000019.10:41009349:C:T	single nucleotide variant	synonymous variant	Likely benign	Feb 7, 2020	no assertion criteria provided							
NM_000767.5(CYP2B6):c.777C>A (p.Ser259Arg)	CYP2B6	S259R	not provided	VCV002649919	19	41515255	19	41009350	2649919	2808716	rs45482602	NC_000019.10:41009349:C:A	single nucleotide variant	missense variant	Likely benign	Sep 1, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.778G>A (p.Ala260Thr)	CYP2B6	A260T	not specified	VCV003837832	19	41515256	19	41009351	3837832	3952453		NC_000019.10:41009350:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 14, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.785A>G (p.Lys262Arg)	CYP2B6	K262R	not provided|Efavirenz response	VCV000120171	19	41515263	19	41009358	120171	125779	rs2279343	NC_000019.10:41009357:A:G	single nucleotide variant	missense variant	Benign	Aug 5, 2015	criteria provided, multiple submitters, no conflicts							
NM_000767.5(CYP2B6):c.789C>A (p.Asp263Glu)	CYP2B6	D263E	not specified	VCV002333156	19	41515267	19	41009362	2333156	2324634	rs2516186553	NC_000019.10:41009361:C:A	single nucleotide variant	missense variant	Uncertain significance	Dec 6, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.795C>T (p.Ile265=)	CYP2B6		CYP2B6-related disorder	VCV003048024	19	41515273	19	41009368	3048024	3209594	rs189970623	NC_000019.10:41009367:C:T	single nucleotide variant	synonymous variant	Likely benign	Aug 14, 2020	no assertion criteria provided							
NM_000767.5(CYP2B6):c.796G>A (p.Asp266Asn)	CYP2B6	D266N	not specified	VCV003837834	19	41515274	19	41009369	3837834	3952455		NC_000019.10:41009368:G:A	single nucleotide variant	missense variant	Uncertain significance	Jan 19, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.797A>T (p.Asp266Val)	CYP2B6	D266V	not specified	VCV002256130	19	41515275	19	41009370	2256130	2246837	rs773494867	NC_000019.10:41009369:A:T	single nucleotide variant	missense variant	Uncertain significance	Oct 20, 2021	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.800C>A (p.Thr267Asn)	CYP2B6	T267N	not specified	VCV004008824	19	41515278	19	41009373	4008824	4125965		NC_000019.10:41009372:C:A	single nucleotide variant	missense variant	Uncertain significance	Apr 12, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.877C>T (p.Leu293Phe)	CYP2B6	L293F	not specified	VCV003499169	19	41515953	19	41010048	3499169	3658229		NC_000019.10:41010047:C:T	single nucleotide variant	missense variant	Uncertain significance	Nov 13, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.881C>T (p.Ser294Leu)	CYP2B6	S294L	not specified	VCV003079503	19	41515957	19	41010052	3079503	3239653	rs1315971029	NC_000019.10:41010051:C:T	single nucleotide variant	missense variant	Uncertain significance	Dec 11, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.919C>G (p.Leu307Val)	CYP2B6	L307V	not specified	VCV003499175	19	41515995	19	41010090	3499175	3658235		NC_000019.10:41010089:C:G	single nucleotide variant	missense variant	Uncertain significance	Dec 10, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.983T>C (p.Ile328Thr)	CYP2B6	I328T	nevirapine response - Toxicity	VCV000225985	19	41518221	19	41012316	225985	227805	rs28399499	NC_000019.10:41012315:T:C	single nucleotide variant	missense variant	drug response	Mar 24, 2021	reviewed by expert panel							
NM_000767.5(CYP2B6):c.985G>A (p.Glu329Lys)	CYP2B6	E329K	not specified	VCV002389414	19	41518223	19	41012318	2389414	2383695	rs370251507	NC_000019.10:41012317:G:A	single nucleotide variant	missense variant	Uncertain significance	Jun 8, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.997G>A (p.Gly333Ser)	CYP2B6	G333S	not specified	VCV002272191	19	41518235	19	41012330	2272191	2261588	rs758110901	NC_000019.10:41012329:G:A	single nucleotide variant	missense variant	Uncertain significance	Mar 20, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1007G>C (p.Arg336Pro)	CYP2B6	R336P	not specified	VCV003079496	19	41518245	19	41012340	3079496	3239646	rs567219326	NC_000019.10:41012339:G:C	single nucleotide variant	missense variant	Uncertain significance	Dec 12, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1007G>A (p.Arg336His)	CYP2B6	R336H	not specified	VCV003079495	19	41518245	19	41012340	3079495	3239645	rs567219326	NC_000019.10:41012339:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 20, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1022A>G (p.His341Arg)	CYP2B6	H341R	not specified	VCV002223076	19	41518260	19	41012355	2223076	2207794	rs553658831	NC_000019.10:41012354:A:G	single nucleotide variant	missense variant	Uncertain significance	Dec 19, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1028G>C (p.Arg343Pro)	CYP2B6	R343P	not specified	VCV002276720	19	41518266	19	41012361	2276720	2262653	rs565980641	NC_000019.10:41012360:G:C	single nucleotide variant	missense variant	Uncertain significance	Feb 10, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1043A>G (p.Tyr348Cys)	CYP2B6	Y348C	not specified	VCV002327826	19	41518281	19	41012376	2327826	2320170	rs2516191878	NC_000019.10:41012375:A:G	single nucleotide variant	missense variant	Uncertain significance	Nov 18, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1081G>A (p.Asp361Asn)	CYP2B6	D361N	not specified	VCV002513790	19	41518319	19	41012414	2513790	2680645	rs375020909	NC_000019.10:41012413:G:A	single nucleotide variant	missense variant	Uncertain significance	May 31, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1132C>T (p.Arg378Ter)	CYP2B6	R378*	Efavirenz response	VCV000143911	19	41518370	19	41012465	143911	153634	rs34097093	NC_000019.10:41012464:C:T	single nucleotide variant	nonsense	drug response	Jan 1, 2006	no assertion criteria provided							
NM_000767.5(CYP2B6):c.1133G>A (p.Arg378Gln)	CYP2B6	R378Q	not specified	VCV003079497	19	41518371	19	41012466	3079497	3239647	rs200458614	NC_000019.10:41012465:G:A	single nucleotide variant	missense variant	Uncertain significance	Sep 29, 2023	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1148C>G (p.Pro383Arg)	CYP2B6	P383R	not specified	VCV003499171	19	41518386	19	41012481	3499171	3658231		NC_000019.10:41012480:C:G	single nucleotide variant	missense variant	Uncertain significance	Oct 6, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1152+9G>A	CYP2B6		CYP2B6-related disorder	VCV003049313	19	41518399	19	41012494	3049313	3212601	rs200334437	NC_000019.10:41012493:G:A	single nucleotide variant	intron variant	Likely benign	Jul 12, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.1153-6C>T	CYP2B6		not provided	VCV003024890	19	41518573	19	41012668	3024890	3185202	rs35449271	NC_000019.10:41012667:C:T	single nucleotide variant	intron variant	Likely benign	Jan 1, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1154A>G (p.Asp385Gly)	CYP2B6	D385G	not specified	VCV003837839	19	41518580	19	41012675	3837839	3952460		NC_000019.10:41012674:A:G	single nucleotide variant	missense variant	Likely benign	Feb 27, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1159G>A (p.Glu387Lys)	CYP2B6	E387K	not specified	VCV002321922	19	41518585	19	41012680	2321922	2311686	rs1969304235	NC_000019.10:41012679:G:A	single nucleotide variant	missense variant	Uncertain significance	Nov 1, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1199A>G (p.His400Arg)	CYP2B6	H400R	not specified	VCV004008820	19	41518625	19	41012720	4008820	4125961		NC_000019.10:41012719:A:G	single nucleotide variant	missense variant	Likely benign	May 16, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1216G>A (p.Asp406Asn)	CYP2B6	D406N	not specified	VCV002303487	19	41518642	19	41012737	2303487	2296726	rs2144677233	NC_000019.10:41012736:G:A	single nucleotide variant	missense variant	Uncertain significance	Jul 26, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1218C>T (p.Asp406=)	CYP2B6		not provided	VCV002649920	19	41518644	19	41012739	2649920	2808717	rs35661880	NC_000019.10:41012738:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 1, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1250A>G (p.Asn417Ser)	CYP2B6	N417S	not specified	VCV003837830	19	41518676	19	41012771	3837830	3952451		NC_000019.10:41012770:A:G	single nucleotide variant	missense variant	Uncertain significance	Jan 1, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1251T>A (p.Asn417Lys)	CYP2B6	N417K	not specified	VCV003079498	19	41518677	19	41012772	3079498	3239648	rs1248271457	NC_000019.10:41012771:T:A	single nucleotide variant	missense variant	Uncertain significance	Feb 21, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1252G>T (p.Gly418Trp)	CYP2B6	G418W	not specified	VCV002410308	19	41518678	19	41012773	2410308	2392445	rs867126676	NC_000019.10:41012772:G:T	single nucleotide variant	missense variant	Uncertain significance	Jul 13, 2022	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1319G>T (p.Gly440Val)	CYP2B6	G440V	not specified	VCV002222623	19	41522575	19	41016670	2222623	2211229	rs758789145	NC_000019.10:41016669:G:T	single nucleotide variant	missense variant	Uncertain significance	Dec 2, 2024	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1322T>C (p.Ile441Thr)	CYP2B6	I441T	not specified	VCV004008819	19	41522578	19	41016673	4008819	4125960		NC_000019.10:41016672:T:C	single nucleotide variant	missense variant	Uncertain significance	May 1, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1323C>T (p.Ile441=)	CYP2B6		CYP2B6-related disorder	VCV003052801	19	41522579	19	41016674	3052801	3219799	rs143488417	NC_000019.10:41016673:C:T	single nucleotide variant	synonymous variant	Likely benign	Dec 24, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.1335A>G (p.Glu445=)	CYP2B6		CYP2B6-related disorder	VCV003053232	19	41522591	19	41016686	3053232	3219192	rs146956370	NC_000019.10:41016685:A:G	single nucleotide variant	synonymous variant	Likely benign	Nov 12, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.1386C>T (p.Pro462=)	CYP2B6		CYP2B6-related disorder	VCV003045935	19	41522642	19	41016737	3045935	3208809	rs368531402	NC_000019.10:41016736:C:T	single nucleotide variant	synonymous variant	Likely benign	Nov 5, 2019	no assertion criteria provided							
NM_000767.5(CYP2B6):c.1414C>T (p.Pro472Ser)	CYP2B6	P472S	not specified	VCV002207371	19	41522670	19	41016765	2207371	2193417	rs147410578	NC_000019.10:41016764:C:T	single nucleotide variant	missense variant	Uncertain significance	May 1, 2025	criteria provided, single submitter							
NM_000767.5(CYP2B6):c.1472G>A (p.Arg491His)	CYP2B6	R491H	not specified	VCV002365434	19	41522728	19	41016823	2365434	2354267	rs148520554	NC_000019.10:41016822:G:A	single nucleotide variant	missense variant	Uncertain significance	Dec 5, 2024	criteria provided, single submitter							
